4 months ago
JAZZ
AnalystsMohit BansalMohit Bansal's Stock Forecasts
AnalystsMohit Bansal
Analyst Ranking
Top 17%
#839 out of 4912 analysts
Average Return
+5.49%
Win Rate
54%50 out of 92
Risk vs Reward
Poor
Good
Mohit Bansal's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avexis IncAVXS | +199.09% | $72.83 | $217.83 | 2017-05-23 - 2018-05-15 | Strong Buy |
Avantor IncAVTR | +175.70% | $10.41 | $28.70 | 2020-03-20 - 2021-03-19 | Strong Buy |
Eli Lilly & CoLLY | +132.66% | $324.49 | $754.95 | 2023-03-12 - 2024-03-12 | Strong Buy |
Avexis IncAVXS | +127.47% | $95.76 | $217.83 | 2017-10-02 - 2018-05-15 | Strong Buy |
Eli Lilly & CoLLY | +89.63% | $425.79 | $807.43 | 2023-05-26 - 2024-05-24 | Strong Buy |
Mohit Bansal Analyst Color
Get additional color on Mohit Bansal's coverage of popular stocks
4 months ago
GILD
5 months ago
LLY
8 months ago
TVTX
10 months ago
LLY
a year ago
BMRN
a year ago
HALO
a year ago
BMRN
a year ago
NBIX
a year ago
LLY
a year ago
LLY
2 years ago
PFE
2 years ago
PFE
2 years ago
LLY
2 years ago
LLY
2 years ago
VRTX
2 years ago
LLY
2 years ago
LLY
2 years ago
PFE
2 years ago
PFE
2 years ago
MRK
3 years ago
LLY
3 years ago
PFE
3 years ago
ABBV
4 years ago
MRK
Mohit Bansal's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals IncREGN | 15 | Hold | $580.00 | +12.93% | Downgrades | 20 days ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $47.00 | +47.34% | Maintains | a month ago |
Halozyme Therapeutics IncHALO | 7 | Hold | $65.00 | +22.30% | Maintains | a month ago |
Bristol Myers Squibb CoBMY | 9 | Hold | $53.00 | +13.15% | Maintains | 2 months ago |
Ironwood Pharmaceuticals IncIRWD | 4 | Hold | $1.00 | +43.06% | Downgrades | 2 months ago |
Eli Lilly & CoLLY | 17 | Strong Buy | $1,100.00 | +40.12% | Maintains | 4 months ago |
Gilead Sciences IncGILD | 11 | Strong Buy | $140.00 | +29.63% | Maintains | 4 months ago |
Abbvie IncABBV | 8 | Strong Buy | $240.00 | +29.39% | Maintains | 4 months ago |
Biogen IncBIIB | 11 | Hold | $140.00 | +10.64% | Maintains | 4 months ago |
Jazz Pharmaceuticals PLCJAZZ | 2 | Strong Buy | $170.00 | +57.06% | Upgrades | 4 months ago |
Vertex Pharmaceuticals IncVRTX | 10 | Hold | $460.00 | +2.59% | Downgrades | 5 months ago |
Amgen IncAMGN | 7 | Hold | $280.00 | -3.32% | Maintains | 5 months ago |
Summit Therapeutics IncSMMT | 1 | Strong Buy | $30.00 | +48.81% | Initiates Coverage On | 6 months ago |
Biontech SeBNTX | 1 | Strong Buy | $170.00 | +62.84% | Initiates Coverage On | 6 months ago |
Vera Therapeutics IncVERA | 1 | Strong Buy | $70.00 | +234.61% | Initiates Coverage On | 7 months ago |
Merck & Co IncMRK | 10 | Hold | $110.00 | +38.73% | Maintains | 8 months ago |
Travere Therapeutics IncTVTX | 4 | Strong Buy | $27.00 | +87.37% | Upgrades | 8 months ago |
Biomarin Pharmaceutical IncBMRN | 4 | Strong Buy | $90.00 | +62.93% | Maintains | 9 months ago |
Pfizer IncPFE | 10 | Hold | $30.00 | +25.63% | Maintains | a year ago |
Neurocrine Biosciences IncNBIX | 7 | Strong Buy | $170.00 | N/A | Upgrades | a year ago |
Chinook Therapeutics IncKDNY | 1 | Hold | $40.00 | N/A | Downgrades | 2 years ago |
Cerevel Therapeutics Holdings IncCERE | 3 | Strong Buy | $30.00 | N/A | Upgrades | 2 years ago |
Mineralys Therapeutics IncMLYS | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 2 years ago |
9 Meters Biopharma IncNMTRQ | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 4 years ago |
Forte Biosciences IncFBRX | 1 | Strong Buy | $1,875.00 | N/A | Initiates Coverage On | 4 years ago |
Gracell Biotechnologies IncGRCL | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 4 years ago |
Radius Health IncRDUS1 | 1 | Strong Buy | $30.00 | N/A | Maintains | 4 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Hold | $175.00 | N/A | Downgrades | 5 years ago |
Shattuck Labs IncSTTK | 1 | Strong Buy | $36.00 | N/A | Initiates Coverage On | 5 years ago |
Myokardia IncMYOK | 1 | Hold | $225.00 | N/A | Downgrades | 5 years ago |
Adaptimmune Therapeutics PLCADAP | 1 | Strong Buy | $5.00 | N/A | Maintains | 5 years ago |
Calithera Biosciences IncCALA | 2 | Strong Buy | $140.00 | N/A | Maintains | 5 years ago |
Avantor IncAVTR | 1 | Strong Buy | $11.00 | N/A | Maintains | 5 years ago |
Audentes Therapeutics IncBOLD1 | 2 | Hold | $28.00 | N/A | Maintains | 7 years ago |
Avexis IncAVXS | 2 | Strong Buy | $116.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.